ENDOMETRIOID CARCINOMA
Clinical trials for ENDOMETRIOID CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIOID CARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIOID CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control OngoingThis Phase I trial tests a combination of two oral drugs, defactinib and VS-6766, in people with advanced solid tumors such as non-small cell lung cancer, low-grade serous ovarian cancer, and pancreatic cancer. The study aims to find the safest dose and evaluate how well the drug…
Matched conditions: ENDOMETRIOID CARCINOMA
Phase: PHASE1 • Sponsor: Institute of Cancer Research, United Kingdom • Aim: Disease control
Last updated Jun 23, 2026 11:57 UTC
-
Less invasive staging for endometrial cancer put to the test
Knowledge-focused OngoingThis study compares a newer, less invasive sentinel node biopsy method to the standard way of staging early-stage endometrial cancers that have a medium or high risk of coming back. The goal is to see if the sentinel node approach causes fewer complications during and after surge…
Matched conditions: ENDOMETRIOID CARCINOMA
Phase: PHASE3 • Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated Jun 23, 2026 12:09 UTC